NCT04345913 2026-03-19Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast CancerNational Cancer Institute (NCI)Phase 1/2 Active not recruiting24 enrolled 24 charts
NCT00365157 2025-07-11Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney DysfunctionNational Cancer Institute (NCI)Phase 1/2 Active not recruiting132 enrolled